section name header

Pronunciation ⬇

sye-ME-ti-deen audio

Indications ⬆ ⬇

REMS

Unlabeled Use:

Action ⬆ ⬇

Therapeutic Effects:

Pharmacokinetics ⬆ ⬇

Absorption: Well absorbed following oral administration.

Distribution: Enters breast milk and cerebrospinal fluid.

Metabolism/Excretion: 30% metabolized by the liver; remainder is eliminated unchanged by the kidneys.

Half-life: 2 hr.

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

CNS: confusion, dizziness, drowsiness, hallucinations, headache.

CV: ARRHYTHMIAS.

GI: constipation, diarrhea, drug-induced hepatitis, nausea.

GU: ↓sperm count, erectile dysfunction.

Endo: gynecomastia.

Hemat: AGRANULOCYTOSIS, APLASTIC ANEMIA, anemia, neutropenia, thrombocytopenia.

Misc: hypersensitivity reactions.

Interactions ⬆ ⬇

Drug-Drug:

Drug-Natural Products:

Route/Dosage ⬆ ⬇

see Calculator

Renal Impairment

Implementation ⬆ ⬇

US Brand Names ⬆ ⬇

Tagamet, Tagamet HB

Canadian Brand Names ⬆ ⬇

Apo-Cimetidine, Novocimetine, Peptol

Classifications ⬆ ⬇

Therapeutic Classification: antiulcer agents

Pharmacologic Classification: histamine h2 antagonists

Availability ⬆ ⬇

(Generic available)

Time/Action Profile ⬆ ⬇

ROUTEONSETPEAKDURATION
PO30 min45–90 min4–5 hr

Assessment ⬆ ⬇

Lab Test Considerations:

Pot. Nursing Diagnoses ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

Code ⬆

NDC Code*